Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Celgene
Gilead Sciences
Massachusetts General Hospital
Celgene
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Fred Hutchinson Cancer Center
Tianjin Medical University Cancer Institute and Hospital
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
University of Birmingham
University of Nebraska
Masonic Cancer Center, University of Minnesota
University of Nebraska
University of Nebraska
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Thomas Jefferson University
University of Southampton
Universität des Saarlandes
Universität des Saarlandes
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
University of Texas Southwestern Medical Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Maryland, Baltimore
SWOG Cancer Research Network
Mayo Clinic
Seagen Inc.
Case Comprehensive Cancer Center
National Heart, Lung, and Blood Institute (NHLBI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Montefiore Medical Center
AIDS Malignancy Consortium
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute